molecular diagnostic test
Jump to navigation
Jump to search
Notes
- results of genetic testing for risk factors for a disease generally do not increase anxiety levels
More general terms
More specific terms
- BRCA1 promoter methylation in leukocytes
- cell-free (circulating tumor) DNA in plasma (liquid biopsy, cFDNA, ctDNA)
- chromosomal breakage in blood by diepoxybutane
- chromosomal translocation
- chromosomal translocation analysis
- chromosomal trisomy testing
- chromosome rearrangement testing
- Comparative analysis using Short Tandem Repeat (STR) markers
- CRISPR; clustered regularly interspaced short palindromic repeats
- Decipher
- deprecated homologous restriction factor
- DNA microarray (gene chip)
- DNA phenotyping
- factor V HR2 haplotype; factor V R2 A4070G mutation
- fecal DNA testing
- FMR1 gene activation
- Galleri blood test
- gene expression ratio
- gene methylation testing
- gene mutation testing; gene mutation analysis
- gene/chromosomal deletion testing
- gene/chromosomal duplication testing
- gene/chromosomal insertion testing
- genotyping (allele testing)
- growth stimulation expressed gene 2 analysis
- HPFH-6 gene in blood
- infectious agent nucleic acid
- microsatellite instability
- multigene testing; expression profile
- multitarget stool RNA; mt-sRNA (Colosense)
- NRas gene in cancer
- nucleic acid panel
- nucleotide repeat testing
- oligonucleotide ligation assay
- Oncotype DX
- PCR for hemophilia RhD
- PCR for tissue typing
- PCR/in-situ hybridization for acute lymphoblastic leukemia
- PCR/in-situ hybridization for acute promyelocytic leukemia
- PIK3CA gene in cancer
- Prolaris
- promoter methylation testing in cancer specimen
- protein/peptide testing
- PTEN (MMAC1) gene in cancer
- restriction enzyme in isolate
- RNA interference; clustered regularly interspaced short palindromic repeats (CRISPR)
- subtelomere analysis
- T-detect COVID test
- telomere analysis
- U-p53AZ in blood (AlzoSure Predict)
- VeriStrat testing
- X-linked heterotaxy in blood/tissue